Clinical Trial Update: Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Lucentis (ranibizumab) and Avastin (bevacizumab) for age-related macular degeneration has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)
• Lucentis (ranibizumab)

Snippet

Sponsor: University of Pennsylvania | Conditions: Age Related Macular Degeneration | Phase 3 | Status: COMPLETED | Results posted: 2012-08-30